Table 3 Predicted number of outcomes for the data by exposure group (E), predicted infected (IP), and predicted symptomatic (SP)

10^-6

29

0.28 (0.12-0.73)

0.2 (0.001-0.69)

10^-6

2

0.13 (0.03-0.42)

0.04 (0–0.27)

2 x 10¹

3

2.14 (0.92-2.79)

2.05 (0.80-2.73)

10^-5

26

2.37 (1.02-5.71)

2.13 (0.06-5.59)

10^-5

5

2.09 (0.61-4.02)

1.12 (0.16-3.39)

2 x 10²

3

2.99 (2.75-3.00)

2.99 (2.56-3.00)

10^-4

24

14.4 (7.85-20.65)

13.85 (3.35-20.61)

10^-4.5

3

2.03 (0.87-2.77)

1.43 (0.44-2.57)

2 x 10³

3

3 (2.99-3.00)

3 (2.89-3.00)

10^-3

27

26.96 (25.56-27)

26.91 (22.63-27)

10^-4

8

6.26 (4.09-7.57)

5.50 (2.97-7.12)

2 x 10⁴

3

3.00 (3.00-3.00)

3.00 (2.95-3.00)

10^-2

28

28 (27.92-28)

28 (26.83-28)

10^-3

5

4.39 (3.80-4.80)

4.30 (3.67-4.74)

2 x 10⁵

3

3.00 (3.00-3.00)

3.00 (2.98-3.00)

10^-1

24

24 (24–24)

24 (23.50-24)

10^-2

4

3.71 (3.23-3.95)

3.69 (3.13-3.94)

2 x 10⁶

3

3.00 (3.00-3.00)

3.00 (2.99-3.00)

10^-1

2

1.91 (1.63-1.99)

1.91 (1.61-1.99)